Key facts
- This page summarizes Jay Pepose's Form 4 filing for Ocuphire Pharma, Inc. (IRD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Jun 2024, 17:30.
Jay Pepose - 11 Jun 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)
- Reporting relationship
- Director
- Issuer ticker
- IRD
- Reported as of
- 11 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Jun 2024, 17:30:15 UTC
- Prior SEC filing
- 15 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Rabourn, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jay Pepose filed Form 4 for Ocuphire Pharma, Inc. (IRD) on 13 Jun 2024.
Change
- Previous filing in this sequence was filed on 15 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCUP
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +41,143
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 180,458
- Date
- 11 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCUP
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +35,181
- Change %
- Price
- $0.000000
- Shares after
- 35,181
- Date
- 11 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,181
- Exercise price
- $1.72
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Footnote F2
The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.